Use of DR6 and P75 antagonists to promote survival of cells of the nervous system

Details for Australian Patent Application No. 2009319864 (hide)

Owner Biogen Idec MA Inc.

Inventors Mi, Sha; Rhodes, Kenneth J.; Pepinsky, R. Blake

Agent Cullens

Pub. Number AU-A-2009319864

PCT Pub. Number WO2010/062904

Priority 61/117,917 25.11.08 US

Filing date 24 November 2009

Wipo publication date 3 June 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

14 July 2011 PCT application entered the National Phase

  PCT publication WO2010/062904 Priority application(s): WO2010/062904

25 August 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Jul 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009319870-Enhanced bioactive formulations of resveratrol

2009319862-A process to remove dissolved AICI3 from ionic liquid